LifeSci Palm Therapeutics Palm Therapeutics is developing first-in-class palmitoylation inhibitors in the oncology space Palm Therapeutics in the News Visit WebsiteShare this...FacebookTwitterLinkedinEmail OTHER COMPANIES Back to All Companies
